Research reveals chaotic schedule for myeloma patients
Myeloma diagnosis can take over five months, requiring several medical consultations
Read More
Author: John Pinching
Modus completes recruitment for sevuparin study
Phase 1b study evaluates effects of sevuparin on the symptoms of volunteer participants
Read More
Navigo and Mannin agree to develop a novel drug for treating COVID-19
Precision X affinity ligand will enable the efficient purification of the non-Fc fusion protein
Read More
Tilt collaborates with MSD on immunotherapy clinical trial
The study will focus on checkpoint inhibitor refractory non-small cell lung cancer
Read More
LumiraDx Partners with British In Vitro Diagnostics Association
Link up will involve reporting on role of rapid diagnostics in taking on antimicrobial resistance
Read More- Kahimmune Therapeutics enters licensing agreement with Gustave Roussy and SATT Paris-Saclay
- IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease
- En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation
- ALK’s EURneffy receives positive CHMP opinion for emergency anaphylaxis treatment in children
- CERo reports encouraging early data from phase 1 trial of CER‑1236
